Posted on October 23rd, 201910/23/19
The General Data Protection Regulation (GDPR) establishes a legal framework that sets guidelines for the collection and processing of personal information from individuals residing in the European Union (EU). GDPR compliance is a challenge for life science companies and services providers alike. Understanding and implementing compliance obligations under the GDPR is an ongoing process that […]
Posted on October 9th, 201910/9/19
In this article, Herbert Lee, PharmD, Senior Vice President, Medical Communications and Pharmacovigilance, makes the case for an integrated approach to ensuring the safe and effective use of medications by patients. From emerging therapies to innovative technologies, the healthcare industry is changing – demanding that we do business differently. Working in one of the most […]
Posted on September 17th, 20199/17/19
A Conversation with Pharmaceutical Commerce & Jim Lang, Chief Executive Officer, EVERSANA Not quite a year ago, an assemblage of pharma service providers came into being as EVERSANA. Funded by two private equity firms with a background in healthcare—Water Street Healthcare Partners and JLL Partners, there were six acquisitions at the time: Dohmen Life Science […]
Posted on September 13th, 20199/13/19
Compliance is a broad and extremely important area in almost every industry and more so in life sciences as it directly and indirectly impacts patient lives. Because the life science industry is continuously evolving, we are challenged to incorporate solutions into our planning that address potential complexities inherent with this evolution. This complex regulatory environment […]
Posted on August 14th, 20198/14/19
A few years ago, we witnessed the heralding of the imminent rise of artificial intelligence (AI) to support medical information services provided through industry-based contact centers. And, in some cases, the message Lonnie Corant Jaman Shuka Rashid Lynn (better known as Common) shares in recent Microsoft commercials is our reality: we have more power at […]
